CLINICAL EVALUATION OF A NEW MYDRIATIC-MYDRILATE.
Cowan
E C
EC
Archer
D
D
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001285:Atropine / Q000008:administration & dosage / Q000009:adverse effects; D003519:Cyclopentolate / Q000008:administration & dosage* / Q000009:adverse effects; D005127:Eye Color / Q000187:drug effects; D005128:Eye Diseases / Q000175:diagnosis; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009184:Mydriatics / Q000008:administration & dosage* / Q000009:adverse effects; D009883:Ophthalmic Solutions / Q000008:administration & dosage* / Q000009:adverse effects; D011680:Pupil / Q000187:drug effects*; D012029:Refraction, Ocular; D014326:Tropanes / Q000008:administration & dosage / Q000009:adverse effects
D009184:Mydriatics; D009883:Ophthalmic Solutions; D014326:Tropanes; D001285:Atropine; C100236:homatropine; D003519:Cyclopentolate